Related Experiment Video
Updated: May 17, 2026
10:43
Differentiation Capacity of Human Aortic Perivascular Adipose Progenitor Cells
Published on: March 5, 2019
Endothelial differentiation and vasculogenesis induced by three-dimensional adipose-derived stem cells
In Su Park1, Soo Hyun Kim, Youngmee Jung
1Center for Biomaterials, Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, Korea.
Anatomical Record (Hoboken, N.J. : 2007)
|October 31, 2012
Summary
Adipose-derived stem cells (ASCs) cultured in 3D cell masses (3DCMs) differentiate into vascular cells. These 3DCMs promote neovascularization, offering potential for regenerative medicine applications.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Angiogenesis Research
Background:
- Adipose-derived stem cells (ASCs) show potential for angiogenic therapy.
- Previous studies explored ASCs in ischemic models.
- The differentiation capacity of ASCs in specific culture conditions requires further investigation.
Purpose of the Study:
- To investigate the differentiation of human ASCs (hASCs) into endothelial cell clusters using 3D cell masses (3DCMs).
- To evaluate the neovascularization potential of hASC-derived 3DCMs in vivo.
- To explore the application of hASC-3DCMs in regenerative medicine.
Main Methods:
- Culturing hASCs in 3D cell masses (3DCMs) to induce differentiation.
- Analyzing 3DCMs for expression of angiogenic factors (VEGF, IL-8) and endothelial markers (CD31, KDR, CD34).
- Injecting 3DCMs mixed with Matrigel/fibrin gel into mice to assess in vivo vascularization.
Main Results:
- hASC-3DCMs induced hypoxic conditions and expressed angiogenic factors.
- Immunochemical staining confirmed endothelial markers (CD31+, KDR+, CD34+) in 3DCMs, unlike monolayer cultures.
- In vivo studies showed mature, blood-perfused microvessels formed from hASC-3DCMs, confirmed by human-specific markers.
Conclusions:
- Three-dimensional cell masses of hASCs promote differentiation into vascular cells.
- hASC-3DCMs effectively induce neovascularization in vivo.
- hASC-3DCMs represent a promising cell source for regenerative medicine and could be co-implanted with other cell types.
